Promising application of dynamic nuclear polarization for in vivo 13C MR imaging

Magnetic Resonance in Medical Sciences

Volumn 10, Issue 4, 2011, Pages 211-217

  Yen, Yi Fen ^a   Nagasawa, Kiyoshi ^b   Nakada, Tsutomu ^b  

^a GE HEALTHCARE   (United States)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Carbon 13 ( 13c); Dynamic nuclear hyperpolarization; Metabolic imaging; MRI

Indexed keywords

CARBON; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ANIMAL; BRAIN; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; HUMAN; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSICS; REVIEW;

ANIMALS; BRAIN; CARBON ISOTOPES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS; PHYSICS; RADIOPHARMACEUTICALS;

EID: 84860248978     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.10.211     Document Type: Review

References (37)

1. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of À10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003; 100:10158-10163.
2. Haake M, Natterer J, Bargon J. Ecient NMR pulse sequences to transfer the parahydrogen-in-duced polarization to hetero nuclei. J Am Chem Soc 1996; 118:8688-8691.
3. 13C an-giography. Magn Reson Med 2001; 46:1-5.
4. Abragam A, Goldman M. Principles of dynamic nuclear polarisation. Rep Prog Phys 1978; 41:395-467.
5. 13C-angiography. Acad Radiol 2002; 9 (Suppl 2):S507-510.
6. Golman K, Ardenkjaer-Larsen JH, Petersson JS, Mansson S, Leunbach I. Molecular imaging with endogenous substances. Proc Natl Acad Sci USA 2003; 100:10435-10439.
7. 13C. Br J Radiol 2003; 76 Spec No 2:S118-127.
8. Svensson J. Contrast-enhanced magnetic resonance angiography: development and optimization of techniques for paramagnetic and hyperpolarized contrast media. Acta Radiol Suppl 2003; 429:1-30.
9. 13C MR angiog-raphy using trueFISP. Magn Reson Med 2003; 50:256-262.
10. 13C. Magn Reson Med 2004; 51:464-472.
11. Johansson E, Olsson LE, Månsson S, et al. Perfu-sion assessment with bolus differentiation: a technique applicable to hyperpolarized tracers. Magn Reson Med 2004; 52:1043-1051.
12. Golman K, In't Zandt R, Thaning M. Real-time metabolic imaging. Proc Natl Acad Sci USA 2006; 103:11270-11275.
13. 13C-1-pyruvate. Magn Reson Med 2007; 58:65-69.
14. 13C magnetic resonance imaging for in vivo tumor diagnosis. Cancer Res 2006; 66: 10855-10860.
15. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
16. 13C imaging-a new diagnostic platform. Eur Radiol 2006; 16:57-67.
17. Chen AP, Albers MJ, Cunningham CH, et al. Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience. Magn Res-on Med 2007; 58:1099-1106.
18. 13C. J Magn Reson 2007; 187:357-362.
19. 13C lactate, pyruvate, and alanine: noninva-sive biomarkers for prostate cancer detection and grading. Cancer Res 2008; 68:8607-8615.
20. Nelson SJ, Vigneron D, Kurhanewicz J, Chen A, Bok R, Hurd R. DNP-hyperpolarized C magnetic resonance metabolic imaging for cancer applications. Appl Magn Reson 2008; 34:533-544.
21. 13C-pyruvate. Mol Imaging Biol 2009; 11:399-407.
22. 13C]-pyruvate metabolism in rat hepatocellular carcinoma. NMR Biomed 2011; 24:506-513.
23. 13C]pyruvate. NMR Biomed 2010; 23:414-423.
24. Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase ‰ux in the heart using hy-perpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci USA 2008; 105:12051-12056.
25. 13C MRI. Magn Reson Med 2008; 59:1005-1013.
26. 13C pyruvate and bicarbonate in the heart. Magn Reson Med 2010; 64:1323-1331.
27. 13C magnetic resonance metabolic imaging: application to brain tumors. Neuro Oncol 2010; 12:133-144.
28. 13C] ethyl pyruvate. Magn Reson Med 2010; 63:1137-1143.
29. 13C]pyruvate using time-resolved MR spectroscopic imaging. J Cereb Blood Flow Metab 2010; 30:1734-1741.
30. 13C magnetic resonance imaging and spec-troscopy. Nat Med 2007; 13:1382-1387.
31. th, Tront, 2008: 888.
32. 13C ketoisocaproate. Int J Cancer 2010; 127:729-736.
33. 13C-labelled bicarbonate. Nature 2008; 453:940-943.
34. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag 2004; 23:57-64.
35. 31P MRS as a method of measuring pH in rat tumours. NMR Biomed 1992; 5:351-359.
36. 31P magnetic resonance spectroscopy study. Cardiovasc Res 2010; 86:82-91.
37. 13C2]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci USA 2009; 106:19801-19806.